U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H11N
Molecular Weight 85.1475
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYCLOPENTYLAMINE

SMILES

NC1CCCC1

InChI

InChIKey=NISGSNTVMOOSJQ-UHFFFAOYSA-N
InChI=1S/C5H11N/c6-5-3-1-2-4-5/h5H,1-4,6H2

HIDE SMILES / InChI

Molecular Formula C5H11N
Molecular Weight 85.1475
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
VCD studies on cyclic peptides assembled from L-α-amino acids and a trans-2-aminocyclopentane- or trans-2-aminocyclohexane carboxylic acid.
2010-11
A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
2010-08-26
Bis[2-(cyclo-pentyl-imino-meth-yl)-5-meth-oxy-phenolato]copper(II).
2010-07-03
Chiral differentiation of some cyclic beta-amino acids by kinetic and fixed ligand methods.
2010-02
2-Bromo-4-chloro-6-(cyclo-pentyl-imino-meth-yl)phenol.
2009-10-03
Chiral differentiation of some cyclopentane and cyclohexane beta-amino acid enantiomers through ion/molecule reactions.
2009-07
Microwave-assisted combinatorial synthesis of new 3-pyrimidin-5-ylpropanamides via a solvent-dependent chemoselective reaction.
2009-03-09
Bis[4-bromo-2-(cyclo-pentyl-imino-meth-yl)phenolato]copper(II).
2009-02-28
N-Cyclo-pentyl-3-(4-hydr-oxy-6-oxo-1,6-dihydro-pyrimidin-5-yl)-3-p-tolyl-propanamide.
2009-02-06
Diastereochemical differentiation of some cyclic and bicyclic beta-amino acids, via the kinetic method.
2009-01
Nucleophilic reaction of cyclopentylamine on phthalimide derivatives: synthesis and antinociceptive activity of products.
2008-06-10
Differentiation of diastereomeric cyclic beta-amino acids by varying the neutral reagent in ion/molecule reactions studied by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
2008
Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination.
2007-12-27
Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.
2007-11-01
Zeolite synthesis using degradable structure-directing agents and pore-filling agents.
2005-02-17
Amino substituted derivatives of 5'-amino-5'-deoxy-5'-noraristeromycin.
2005-02-01
Inhibition of nucleoside transport proteins by C8-alkylamine-substituted purines.
2005-01-13
Phenyl- and cyclopentylimino derivatization for double bond location in unsaturated C(37)-C(40) alkenones by GC-MS.
2004-08
Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') group.
2004-05-03
Synthesis of carbocyclic phosphononucleosides.
2001-09-21
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:53:03 GMT 2025
Edited
by admin
on Mon Mar 31 19:53:03 GMT 2025
Record UNII
4259VRY3GN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-32389
Preferred Name English
CYCLOPENTYLAMINE
Systematic Name English
CYCLOPENTANAMINE
Systematic Name English
AMINOCYCLOPENTANE
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
213-697-3
Created by admin on Mon Mar 31 19:53:03 GMT 2025 , Edited by admin on Mon Mar 31 19:53:03 GMT 2025
PRIMARY
CAS
1003-03-8
Created by admin on Mon Mar 31 19:53:03 GMT 2025 , Edited by admin on Mon Mar 31 19:53:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID4061387
Created by admin on Mon Mar 31 19:53:03 GMT 2025 , Edited by admin on Mon Mar 31 19:53:03 GMT 2025
PRIMARY
PUBCHEM
2906
Created by admin on Mon Mar 31 19:53:03 GMT 2025 , Edited by admin on Mon Mar 31 19:53:03 GMT 2025
PRIMARY
FDA UNII
4259VRY3GN
Created by admin on Mon Mar 31 19:53:03 GMT 2025 , Edited by admin on Mon Mar 31 19:53:03 GMT 2025
PRIMARY
NSC
32389
Created by admin on Mon Mar 31 19:53:03 GMT 2025 , Edited by admin on Mon Mar 31 19:53:03 GMT 2025
PRIMARY